Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $4.97M | $0.61 | $32.67 | 5,299.50% | Buy | 3 | N/A | N/A | N/A | N/A | |||
| FBLG | FIBROBIOLOGICS INC | $20.58M | $0.40 | $10.00 | 2,400.00% | Strong Buy | 2 | N/A | N/A | -27,292.30% | -390.16% | |||
| PSTV | PLUS THERAPEUTICS INC | $37.11M | $0.27 | $6.75 | 2,400.00% | Strong Buy | 4 | 105.62% | N/A | 693.40% | 187.70% | |||
| NRXP | NRX PHARMACEUTICALS INC | $60.97M | $2.17 | $36.75 | 1,593.55% | Strong Buy | 4 | 1,549.32% | N/A | -610.91% | 1,049.22% | |||
| SKYE | SKYE BIOSCIENCE INC | $32.38M | $1.01 | $15.00 | 1,385.15% | Buy | 2 | N/A | N/A | -173.77% | -138.08% | |||
| SGMO | SANGAMO THERAPEUTICS INC | $127.53M | $0.38 | $5.50 | 1,351.19% | Buy | 2 | 86.54% | N/A | 4,425.69% | 311.69% | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $402.59M | $3.72 | $51.17 | 1,275.46% | Buy | 6 | N/A | N/A | -24.99% | -21.30% | |||
| OSTX | OS THERAPIES INC | $51.77M | $1.47 | $18.50 | 1,158.50% | Strong Buy | 2 | N/A | N/A | -85.59% | -34.77% | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $26.24M | $1.08 | $13.00 | 1,103.70% | Strong Buy | 2 | N/A | N/A | 66.62% | 55.62% | |||
| TLRY | TILRAY BRANDS INC | $1.05B | $9.05 | $105.00 | 1,060.22% | Buy | 2 | 4.70% | N/A | 6.02% | 4.53% | |||
| FEMY | FEMASYS INC | $36.55M | $0.63 | $7.25 | 1,060.00% | Strong Buy | 2 | 177.96% | N/A | 39.28% | 10.99% | |||
| NAKA | KINDLY MD INC | $177.26M | $0.40 | $4.50 | 1,016.63% | Strong Buy | 2 | 1,384.79% | N/A | 0.94% | 0.65% | |||
| ACET | ADICET BIO INC | $80.84M | $8.44 | $89.00 | 954.50% | Strong Buy | 2 | N/A | N/A | 17.66% | 13.72% | |||
| SLE | SUPER LEAGUE ENTERPRISE INC | $4.95M | $5.90 | $60.00 | 916.95% | Strong Buy | 2 | N/A | N/A | N/A | -6.33% | |||
| IFRX | INFLARX NV | $68.42M | $1.01 | $10.00 | 890.10% | Buy | 3 | 102.69% | N/A | -29.23% | -20.35% | |||
| SLN | SILENCE THERAPEUTICS PLC | $267.55M | $5.67 | $55.00 | 870.02% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $37.51M | $0.33 | $3.14 | 864.11% | Strong Buy | 7 | N/A | N/A | -141.87% | -45.04% | |||
| SNTI | SENTI BIOSCIENCES INC | $28.39M | $1.08 | $10.33 | 856.76% | Strong Buy | 3 | N/A | N/A | -549.81% | -84.75% | |||
| IOBT | IO BIOTECH INC | $26.41M | $0.37 | $3.50 | 853.68% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| PDSB | PDS BIOTECHNOLOGY CORP | $46.53M | $0.95 | $9.00 | 847.37% | Strong Buy | 2 | N/A | N/A | 237.82% | 64.78% | |||
| IMUX | IMMUNIC INC | $82.64M | $0.69 | $6.33 | 821.83% | Strong Buy | 3 | N/A | N/A | 217.34% | 56.06% | |||
| ATYR | ATYR PHARMA INC | $70.84M | $0.72 | $6.33 | 775.93% | Buy | 3 | 640.31% | N/A | 79.97% | 60.16% | |||
| MYO | MYOMO INC | $35.05M | $0.91 | $7.50 | 722.37% | Buy | 2 | 20.27% | N/A | 79.63% | 34.18% | |||
| MSAI | MULTISENSOR AI HOLDINGS INC | $17.76M | $0.34 | $2.75 | 713.61% | Strong Buy | 2 | 75.67% | N/A | N/A | N/A | |||
| TVRD | TVARDI THERAPEUTICS INC | $44.00M | $4.69 | $38.00 | 710.23% | Strong Buy | 2 | -100.00% | N/A | -69.71% | -49.78% | |||
| HUMA | HUMACYTE INC | $196.63M | $1.05 | $8.50 | 709.52% | Strong Buy | 6 | 480.57% | N/A | -15,036.89% | 780.69% | |||
| VERU | VERU INC | $44.94M | $2.80 | $22.50 | 703.57% | Strong Buy | 2 | N/A | N/A | -117.88% | -72.43% | |||
| VNRX | VOLITIONRX LTD | $34.63M | $0.28 | $2.25 | 697.87% | Strong Buy | 2 | 337.69% | N/A | -401.43% | 2,155.97% | |||
| CTSO | CYTOSORBENTS CORP | $42.71M | $0.68 | $5.38 | 690.44% | Buy | 2 | 33.22% | N/A | N/A | N/A | |||
| PALI | PALISADE BIO INC | $284.60M | $1.91 | $14.67 | 667.91% | Strong Buy | 3 | N/A | N/A | -1,443.18% | -664.78% | |||
| PMN | PROMIS NEUROSCIENCES INC | $20.30M | $9.43 | $71.50 | 658.22% | Strong Buy | 2 | N/A | N/A | -337.19% | -144.37% | |||
| CING | CINGULATE INC | $32.97M | $4.88 | $37.00 | 658.20% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $168.90M | $1.39 | $10.50 | 655.40% | Strong Buy | 2 | 196.39% | N/A | N/A | -543.98% | |||
| TNYA | TENAYA THERAPEUTICS INC | $121.55M | $0.73 | $5.33 | 630.55% | Strong Buy | 3 | N/A | N/A | 702.97% | 554.90% | |||
| ZSPC | ZSPACE INC | $16.27M | $0.56 | $4.00 | 614.29% | Strong Buy | 2 | N/A | N/A | N/A | -178.34% | |||
| JSPR | JASPER THERAPEUTICS INC | $43.93M | $1.57 | $11.20 | 613.38% | Buy | 5 | N/A | N/A | -151.71% | -30.55% | |||
| HOWL | WEREWOLF THERAPEUTICS INC | $32.76M | $0.68 | $4.67 | 591.41% | Strong Buy | 3 | N/A | N/A | -216.51% | -80.52% | |||
| ONCY | ONCOLYTICS BIOTECH INC | $128.51M | $1.24 | $8.50 | 585.48% | Strong Buy | 2 | N/A | N/A | N/A | N/A | |||
| HELP | CYBIN INC | $173.67M | $7.54 | $49.33 | 554.28% | Strong Buy | 3 | N/A | N/A | -51.47% | -39.47% | |||
| KRRO | KORRO BIO INC | $101.05M | $10.73 | $69.00 | 543.06% | Buy | 5 | -28.54% | N/A | -84.00% | -51.49% | |||
| CLNN | CLENE INC | $54.87M | $5.31 | $34.00 | 540.30% | Strong Buy | 3 | 772.11% | N/A | -497.31% | 275.43% | |||
| BMEA | BIOMEA FUSION INC | $94.74M | $1.34 | $8.25 | 515.67% | Strong Buy | 4 | N/A | N/A | -443.26% | -125.45% | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $21.76M | $1.90 | $11.50 | 505.26% | Strong Buy | 2 | 555.84% | N/A | -2.51% | -1.66% |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.